Asthma exacerbations. 5: assessment and management of severe asthma in adults in hospital.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMC 2117186)

Published in Thorax on May 01, 2007

Authors

Sarah Aldington1, Richard Beasley

Author Affiliations

1: Medical Research Institute of New Zealand, P O Box 10055, Wellington, New Zealand.

Articles cited by this

The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med (1992) 8.53

Edinburgh emergency asthma admission service. Br Med J (1975) 8.40

Assessment and management of severe asthma. Am J Med (1971) 7.43

Asthma: analysis of sudden deaths and ventilatory arrests in hospital. Br Med J (1977) 6.16

Differences in hospital asthma management. Lancet (1988) 5.86

Perception of asthma. Lancet (1976) 4.47

Accuracy of perception of severity of asthma: patients treated in general practice. BMJ (1993) 3.99

A case-control study of deaths from asthma. Thorax (1986) 3.97

New regression equations for predicting peak expiratory flow in adults. BMJ (1989) 3.62

Asthma severity and adequacy of management in accident and emergency departments in France: a prospective study. Lancet (2001) 3.52

Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial. Lancet (2003) 3.52

Acute bronchial asthma. Relations between clinical and physiologic manifestations. N Engl J Med (1973) 3.09

Arterial-blood gas tension in asthma. N Engl J Med (1968) 2.91

Guidelines on the management of asthma. Statement by the British Thoracic Society, the Brit. Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal College of General Practitioners, the General Practitioners in Asthma Group, the Brit. Assoc. of Accident and Emergency Medicine, and the Brit. Paediatric Respiratory Group. Thorax (1993) 2.83

Sudden death in asthma. Thorax (1979) 2.72

The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61

Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest (1993) 2.49

Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax (2005) 2.41

Guidelines for management of asthma in adults: II--Acute severe asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign. BMJ (1990) 2.34

A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest (1993) 2.15

Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med (1998) 2.15

Acute asthma. Admission chest radiography in hospitalized adult patients. Chest (1991) 2.14

Effect of a preprinted form on the management of acute asthma in an accident and emergency department. J Accid Emerg Med (1996) 2.09

Heliox vs air-oxygen mixtures for the treatment of patients with acute asthma: a systematic overview. Chest (2003) 2.08

Asthma. Lancet (1995) 2.03

Vocal-cord dysfunction presenting as asthma. N Engl J Med (1983) 2.02

Double-blind trial of steroid tapering in acute asthma. Lancet (1993) 2.01

The effect of heliox in acute severe asthma: a randomized controlled trial. Chest (1999) 2.00

Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92

Vocal cord dysfunction and wheezing. Thorax (1991) 1.82

References values for forced spirometry. Group of the European Community Respiratory Health Survey. Eur Respir J (1998) 1.68

Effectiveness of steroid therapy in acute exacerbations of asthma: a meta-analysis. Am J Emerg Med (1992) 1.68

Dose response of patients to oral corticosteroid treatment during exacerbations of asthma. Br Med J (Clin Res Ed) (1986) 1.68

Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis (1992) 1.63

Aerosolized magnesium sulfate for acute asthma: a systematic review. Chest (2005) 1.57

Acute severe asthma. Am J Respir Crit Care Med (2003) 1.50

Use of helium-oxygen mixtures in the treatment of acute asthma: a systematic review. Chest (2003) 1.50

Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. Am J Respir Crit Care Med (2005) 1.48

Preservatives in nebulizer solutions: risks without benefit. Pharmacotherapy (1998) 1.47

Call for worldwide withdrawal of benzalkonium chloride from nebulizer solutions. J Allergy Clin Immunol (2001) 1.46

Need for intravenous hydrocortisone in addition to oral prednisolone in patients admitted to hospital with severe asthma without ventilatory failure. Lancet (1986) 1.44

High-dose inhaled versus intravenous salbutamol combined with theophylline in severe acute asthma. Swedish Society of Chest Medicine. Eur Respir J (1990) 1.42

Use of a management plan for treating asthma in an emergency department. Thorax (1990) 1.40

Comparison of 2.5 vs 7.5 mg of inhaled albuterol in the treatment of acute asthma. Chest (1999) 1.40

National audit of acute severe asthma in adults admitted to hospital. Standards of Care Committee, British Thoracic Society. Qual Health Care (1995) 1.39

The use of structured, complaint-specific patient encounter forms in the emergency department. Ann Emerg Med (1993) 1.39

Nebulised salbutamol without oxygen in severe acute asthma: how effective and how safe? Thorax (1985) 1.36

Routine antibiotics in hospital management of acute asthma. Lancet (1982) 1.33

Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care. Thorax (1996) 1.27

Rapid prediction of need for hospitalization in acute asthma. JAMA (1976) 1.23

Noninvasive positive pressure ventilation in status asthmaticus. Chest (1996) 1.21

Effect of an emergency department asthma program on acute asthma care. Ann Emerg Med (1999) 1.13

Emergency room radiography of asthma: an efficacy study. Radiology (1982) 1.13

A comparison of 'abruptly stopping' with 'tailing off' oral corticosteroids in acute asthma. Respir Med (1995) 1.10

A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest (2003) 1.10

Are doctors still failing to assess and treat asthma attacks? An audit of the management of acute attacks in a health district. Respir Med (1999) 1.08

Emergency room assessment and treatment of patients with acute asthma. Adequacy of the conventional approach. Am J Med (1978) 1.06

Heliox improves pulsus paradoxus and peak expiratory flow in nonintubated patients with severe asthma. Am J Respir Crit Care Med (1995) 1.06

Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Syst Rev (2000) 1.05

Anticholinergic blockade of beta-blocker-induced bronchoconstriction. Am Rev Respir Dis (1989) 1.05

Mechanical load and inspiratory muscle action during induced asthma. Am Rev Respir Dis (1983) 1.00

Arterial blood gas analysis or oxygen saturation in the assessment of acute asthma? Thorax (1995) 1.00

The assessment and management of adults with status asthmaticus. Am J Respir Crit Care Med (1995) 0.99

Rapid-onset asthma attack: a prospective cohort study about characteristics and response to emergency department treatment. Chest (2000) 0.98

Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution. Thorax (1988) 0.94

Use of heliox-driven nebulizer therapy in the treatment of acute asthma. Ann Emerg Med (1999) 0.93

The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group. Chest (1997) 0.93

Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am Rev Respir Dis (1992) 0.92

Classification of asthma severity: should the international guidelines be changed? Clin Exp Allergy (1998) 0.92

Arterial blood gases and pulmonary function testing in acute bronchial asthma. Predicting patient outcomes. JAMA (1983) 0.91

Oxygen therapy in acute medical care. BMJ (2002) 0.91

Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest (2000) 0.90

Peak-flow percentage in asthma. Lancet (1971) 0.90

Has oxygen administration delayed appropriate respiratory care? Fallacies regarding oxygen therapy. Respir Care (2003) 0.89

Protocol therapy for acute asthma: therapeutic benefits and cost savings. Am J Med (1995) 0.88

Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. Am J Respir Crit Care Med (1994) 0.87

An attempt to determine the optimal duration of hospital stay following a severe attack of asthma. J R Coll Physicians Lond (1990) 0.87

The relationship between FEV1 and PEF in the assessment of the severity of airways obstruction. Respirology (2002) 0.87

Corticosteroids in acute severe asthma: effectiveness of low doses. Thorax (1992) 0.86

Continuous vs intermittent albuterol, at high and low doses, in the treatment of severe acute asthma in adults. Chest (1996) 0.86

Increased inspired oxygen concentration may delay diagnosis and treatment of significant deterioration in pulmonary function. Crit Care Med (1999) 0.86

Sudden-onset asthma exacerbations: clinical features, response to therapy, and 2-week follow-up. Multicenter Airway Research Collaboration (MARC) investigators. Eur Respir J (2000) 0.85

Continuous versus intermittent albuterol nebulization in the treatment of acute asthma. Ann Emerg Med (1993) 0.84

Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department. Ann Emerg Med (1993) 0.84

Asthma--expiratory dyspnoea? Br Med J (Clin Res Ed) (1981) 0.81

Critical pathway for the emergency department management of acute asthma: effect on resource utilization. Ann Emerg Med (1998) 0.81

Acute dose-response studies in bronchial asthma with a new corticosteroid, budesonide. Br J Clin Pharmacol (1983) 0.81

As-required versus regular nebulized salbutamol for the treatment of acute severe asthma. Eur Respir J (1999) 0.80

Comparison of the process of care of acute severe asthma in adults admitted to hospital before and 1 yr after the publication of national guidelines. Respir Med (1996) 0.79

Do accident and emergency senior house officers know the British guidelines on the management of acute asthma? Postgrad Med J (1996) 0.76

Acute severe asthma. Respir Med (1991) 0.76

How long should Atrovent be given in acute asthma? Thorax (1998) 0.76

Acute adult asthma--assessment of severity and management and comparison with British Thoracic Society Guidelines. Respir Med (1999) 0.76

Articles by these authors

(truncated to the top 100)

The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy (2004) 13.16

Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2007) 4.67

Acetaminophen for Fever in Critically Ill Patients with Suspected Infection. N Engl J Med (2015) 3.57

Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial. Lancet (2003) 3.52

Tiotropium Respimat increases the risk of mortality. Thorax (2013) 3.34

PHARMAC and tobacco control in New Zealand: government policy 'up in smoke'. N Z Med J (2005) 2.54

A pilot study investigating the effects of remote ischemic preconditioning in high-risk cardiac surgery using a randomised controlled double-blind protocol. Basic Res Cardiol (2012) 2.37

Limited generalisability of UPLIFT findings to clinical practice. Thorax (2013) 2.15

Randomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma. Thorax (2011) 2.11

Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One (2010) 2.04

Buteyko pseudoscience. N Z Med J (2004) 2.02

British National Formulary for Children: the risk of inappropriate paracetamol prescribing. Arch Dis Child (2011) 1.88

Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations. Ann Allergy Asthma Immunol (2004) 1.84

Effects of cannabis on pulmonary structure, function and symptoms. Thorax (2007) 1.79

Six-month in vitro validation of a metered-dose inhaler electronic monitoring device: implications for asthma clinical trial use. J Allergy Clin Immunol (2012) 1.78

External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax (2006) 1.72

Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med (2006) 1.71

Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. Lancet Respir Med (2013) 1.66

Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma. Respirology (2014) 1.64

How to write research papers and grants: 2011 Asian Pacific Society for Respirology Annual Scientific Meeting Postgraduate Session. Respirology (2012) 1.58

Aerosolized magnesium sulfate for acute asthma: a systematic review. Chest (2005) 1.57

Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med (2007) 1.56

Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data. Clin Ther (2004) 1.55

The New Zealand national junior doctors' strike: implications for the provision of acute hospital medical services. Clin Med (2008) 1.53

The all-age spirometry reference ranges reflect contemporary Australasian spirometry. Respirology (2011) 1.52

Complete reference ranges for pulmonary function tests from a single New Zealand population. N Z Med J (2006) 1.52

Tiotropium Respimat increases the risk of mortality: pro. Eur Respir J (2013) 1.51

Do natural health food stores require regulation? N Z Med J (2002) 1.47

Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis. N Z Med J (2005) 1.46

Pilot study of the safety and effect of intranasal delipidated acid-treated Mycobacterium vaccae in adult asthma. Respirology (2003) 1.46

Is it time to change the approach to oxygen therapy in the breathless patient? Thorax (2007) 1.45

COX-2 inhibitors--first, do no harm. N Z Med J (2005) 1.38

High blood pressure advice given by natural health food stores. N Z Med J (2009) 1.38

External validity of randomized controlled trials in COPD. Respir Med (2006) 1.30

Early peak temperature and mortality in critically ill patients with or without infection. Intensive Care Med (2012) 1.29

The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. J R Soc Med (2010) 1.21

Physiological associations of computerized tomography lung density: a factor analysis. Int J Chron Obstruct Pulmon Dis (2006) 1.18

Arterial oxygen tension and mortality in mechanically ventilated patients. Intensive Care Med (2011) 1.17

The use of the self-management plan system of care in adult asthma. Prim Care Respir J (2004) 1.17

Honey in the treatment of burns: a systematic review and meta-analysis of its efficacy. N Z Med J (2009) 1.16

Prolonged work- and computer-related seated immobility and risk of venous thromboembolism. J R Soc Med (2010) 1.15

The Global Lung Initiative 2012 reference values reflect contemporary Australasian spirometry. Respirology (2012) 1.11

The association between SpO2 values and mortality--interpret with caution. Resuscitation (2012) 1.08

Raised plasma homocysteine levels in alcoholism: increasing the risk of heart disease and dementia? N Z Med J (2005) 1.07

Seasonal variation in asthma-related hospital and intensive care unit admissions. J Asthma (2005) 1.05

The effect of hyperoxia following cardiac arrest - A systematic review and meta-analysis of animal trials. Resuscitation (2012) 1.05

Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J (2009) 1.04

Use of metered-dose inhaler electronic monitoring in a real-world asthma randomized controlled trial. J Allergy Clin Immunol Pract (2012) 1.01

Utility of lung density measurements in the diagnosis of emphysema. Respir Med (2007) 1.01

Early temperature and mortality in critically ill patients with acute neurological diseases: trauma and stroke differ from infection. Intensive Care Med (2015) 0.99

Accuracy of patient self-report as a measure of inhaled asthma medication use. Respirology (2013) 0.98

Venous thromboembolism in medical inpatients--the silent epidemic of neglect. J R Soc Med (2005) 0.97

A case-control study of seated immobility at work as a risk factor for venous thromboembolism. J R Soc Med (2008) 0.97

Fever and fever management among intensive care patients with known or suspected infection: a multicentre prospective cohort study. Crit Care Resusc (2011) 0.96

The worldwide association between television viewing and obesity in children and adolescents: cross sectional study. PLoS One (2013) 0.95

The association between tobacco and the risk of asthma, rhinoconjunctivitis and eczema in children and adolescents: analyses from Phase Three of the ISAAC programme. Thorax (2012) 0.94

An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. J Allergy Clin Immunol (2007) 0.94

Dose-response relationship of inhaled corticosteroids and cataracts: a systematic review and meta-analysis. Respirology (2009) 0.94

Cannabis use and cancer of the head and neck: case-control study. Otolaryngol Head Neck Surg (2008) 0.93

Call for worldwide withdrawal of tiotropium Respimat mist inhaler. BMJ (2012) 0.92

The acetaminophen and asthma hypothesis 10 years on: A case to answer. J Allergy Clin Immunol (2009) 0.92

Randomised placebo-controlled study of the effect of paracetamol on asthma severity in adults. BMJ Open (2014) 0.91

Asthma: time to confront some inconvenient truths. Respirology (2010) 0.89

The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler. Respir Med (2005) 0.88

Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma. J Allergy Clin Immunol (2010) 0.88

Towards individualised treatment in COPD. Thorax (2011) 0.87

An inverse correlation between estimated tuberculosis notification rates and asthma symptoms. Respirology (2002) 0.87

Hospital admissions for chronic obstructive pulmonary disease in New Zealand. N Z Med J (2015) 0.87

The relationship between FEV1 and PEF in the assessment of the severity of airways obstruction. Respirology (2002) 0.87

High-concentration versus titrated oxygen therapy in ST-elevation myocardial infarction: a pilot randomized controlled trial. Am Heart J (2012) 0.86

Metered dose inhalers: a need for dose counters. Respirology (2005) 0.86

Efficacy of micromobile foot compression device in increasing lower limb venous blood flow. Int J Vasc Med (2013) 0.85

Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev (2012) 0.85

The multiple dimensions of airways disease: targeting treatment to clinical phenotypes. Curr Opin Pulm Med (2011) 0.85

A systematic review of the accuracy of peripheral thermometry in estimating core temperatures among febrile critically ill patients. Crit Care Resusc (2011) 0.83

The value of the CRB65 score to predict mortality in exacerbations of COPD requiring hospital admission. Respirology (2011) 0.83

Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial. Thorax (2013) 0.83

The risk of serious adverse outcomes associated with hypoxaemia and hyperoxaemia in acute exacerbations of COPD. Postgrad Med J (2012) 0.83

Supplementary oxygen for nonhypoxemic patients: O2 much of a good thing? Crit Care (2011) 0.83

Occupational risk factors for chronic respiratory disease in a New Zealand population using lifetime occupational history. J Occup Environ Med (2014) 0.83

The association between early arterial oxygenation and mortality in ventilated patients with acute ischaemic stroke. Crit Care Resusc (2012) 0.82

Merino wool graduated compression stocking increases lower limb venous blood flow: a randomized controlled trial. Adv Ther (2011) 0.82

The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler. Respir Med (2004) 0.82

Understanding the true burden of COPD: the epidemiological challenges. Prim Care Respir J (2012) 0.82

Has Coxiella burnetii (Q fever) been introduced into New Zealand? Emerg Infect Dis (2003) 0.82

Inconsistencies in cardiovascular data from COX-2 inhibitor trials--is it a class effect? J R Soc Med (2006) 0.81

International trends in asthma mortality rates in the 5- to 34-year age group: a call for closer surveillance. Chest (2009) 0.81

Systematic review and meta-analysis of the effects of antipyretic medications on mortality in Streptococcus pneumoniae infections. Postgrad Med J (2011) 0.80

Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma? Expert Rev Respir Med (2013) 0.80

Randomized controlled trial of high concentration oxygen in suspected community-acquired pneumonia. J R Soc Med (2012) 0.80

Budesonide once versus twice-daily administration: meta-analysis. Respirology (2004) 0.80

Leukotriene receptor antagonist therapy and Churg-Strauss syndrome: culprit or innocent bystander? Thorax (2008) 0.80

Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome. J Allergy Clin Immunol (2012) 0.79

Systematic review and meta-analysis of the risk of major cardiovascular events with etoricoxib therapy. N Z Med J (2005) 0.79

Incidental findings from lung CT scans: implications for research. J Med Imaging Radiat Oncol (2011) 0.79

Long-acting beta-agonists and asthma death: how useful are different study designs to evaluate the potential association? J Asthma (2010) 0.79

Lung cancer in Maori: a neglected priority. N Z Med J (2005) 0.79

Hospital admissions for non-cystic fibrosis bronchiectasis in New Zealand. N Z Med J (2015) 0.79

Avoidance of high concentration oxygen in chronic obstructive pulmonary disease. BMJ (2010) 0.79

The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol. Respirology (2004) 0.78